ROTH/MKM bullish on Research Solutions stock, cites record revenue and AEBITDA growth

Published 20/09/2024, 11:22
ROTH/MKM bullish on Research Solutions stock, cites record revenue and AEBITDA growth


On Friday, Research Solutions Inc. (NASDAQ:RSSS) stock maintained its Buy rating with a consistent price target of $4.35, as confirmed by Roth/MKM. The company reported a robust performance for the fourth quarter of fiscal year 2024, with record revenues of $12.1 million, marking a 22% increase year-over-year. This figure surpassed both the analyst's projection of $11.5 million and the previous quarter's record, despite the fourth quarter typically experiencing a seasonal dip in performance.

The company's Adjusted EBITDA reached a record $1.4 million, which was notably twice the anticipated $0.7 million estimate. This significant growth, amounting to a 70% year-over-year increase, was attributed to the benefits of scale and cost leverage brought about by recent acquisitions. The financial results indicated a strong close to the fiscal year for Research Solutions.

Despite the fourth quarter's better-than-expected results, the forecasts for fiscal year 2025's revenue and earnings have been left largely unchanged. The firm's stance remains cautiously conservative, suggesting confidence in the company's stability and future performance without adjusting expectations based on the recent positive results.

The analyst from Roth/MKM highlighted the acquisition-enhanced scale and cost leverage as key factors contributing to the company's impressive Adjusted EBITDA. The statement provided by the firm underscored the strategic benefits that have led to the company's current financial standing.

In summary, Research Solutions Inc. has retained its Buy rating with a price target of $4.35, as the company's fourth-quarter financials demonstrated solid growth and profitability. The analyst's outlook remains cautiously optimistic, with forecasts for the forthcoming fiscal year staying steady in the face of the recent positive financial outcomes.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.